A vial labelled with the Pfizer-BioNTech coronavirus ailment (COVID-19) vaccine is viewed in this illustration picture taken March 19, 2021. REUTERS/Dado Ruvic/Illustration
ny, Oct 21 (Reuters) - The Pfizer (PFE.N)/BioNTech COVID-19 vaccine confirmed ninety.7% efficacy towards the coronavirus in a clinical trial of five to eleven 12 months olds, the U.S. drugmaker observed on Friday.
Sixteen toddlers in the trial who had received a placebo obtained COVID-19, in comparison with three who have been vaccinated, Pfizer spoke of in briefing documents submitted to the U.S. meals and Drug Administration.
as a result of greater than twice as many children in the 2,268-participant trial were given the vaccine than placebo, that equates to more desirable than 90% efficacy.
backyard advisors to the FDA are scheduled to fulfill on Tuesday to vote on even if to suggest that the agency approve the vaccine for that age group.
Reporting via Michael Erman; enhancing via John Stonestreet
Our requisites: The Thomson Reuters have confidence principles.
0 Comments